Matches in Wikidata for { <http://www.wikidata.org/entity/Q99400507> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q99400507 description "article scientifique publié en 2020" @default.
- Q99400507 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q99400507 description "scientific article published on 24 August 2020" @default.
- Q99400507 description "wetenschappelijk artikel" @default.
- Q99400507 description "наукова стаття, опублікована 24 серпня 2020" @default.
- Q99400507 name "Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound" @default.
- Q99400507 name "Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound" @default.
- Q99400507 type Item @default.
- Q99400507 label "Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound" @default.
- Q99400507 label "Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound" @default.
- Q99400507 prefLabel "Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound" @default.
- Q99400507 prefLabel "Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound" @default.
- Q99400507 P1433 Q99400507-292FABBB-7509-489F-BAFA-056E6BF373F4 @default.
- Q99400507 P1476 Q99400507-8028D8B3-C3D0-4580-B072-0429D0201A34 @default.
- Q99400507 P2093 Q99400507-5FDED164-BD22-4C41-82A9-53E16CB5213C @default.
- Q99400507 P2093 Q99400507-B1B66352-3907-4198-8899-0C47346CD912 @default.
- Q99400507 P2093 Q99400507-B4EE8662-DF12-4663-81C4-1EB31A391708 @default.
- Q99400507 P2093 Q99400507-D19C5611-FEB2-4D22-B1A4-04E55E46CF34 @default.
- Q99400507 P2093 Q99400507-EED11945-A469-42C6-AE34-16364F9AF1A8 @default.
- Q99400507 P304 Q99400507-7758DD26-4537-4490-A78D-05C7CDD1B340 @default.
- Q99400507 P31 Q99400507-AC52AC04-28B5-41AA-BA6A-383227C457B8 @default.
- Q99400507 P356 Q99400507-E5FA9A46-C5B4-493E-AFD3-CE4F9092B434 @default.
- Q99400507 P478 Q99400507-D8B098B5-CAA6-46E3-B163-9C65599E09DF @default.
- Q99400507 P577 Q99400507-FA58005F-58D4-47D6-8842-9844F8558C09 @default.
- Q99400507 P698 Q99400507-206BDD13-10F9-403D-B9DA-D3033E7BE171 @default.
- Q99400507 P356 J.EJOGRB.2020.08.040 @default.
- Q99400507 P698 32920421 @default.
- Q99400507 P1433 Q15755730 @default.
- Q99400507 P1476 "Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound" @default.
- Q99400507 P2093 "Elisabeth Epstein" @default.
- Q99400507 P2093 "Elizabeth A Stewart" @default.
- Q99400507 P2093 "Johanna K Andersson" @default.
- Q99400507 P2093 "Kristina Gemzell-Danielsson" @default.
- Q99400507 P2093 "Raffaella Pozzi Mucelli" @default.
- Q99400507 P304 "38-43" @default.
- Q99400507 P31 Q13442814 @default.
- Q99400507 P356 "10.1016/J.EJOGRB.2020.08.040" @default.
- Q99400507 P478 "254" @default.
- Q99400507 P577 "2020-08-24T00:00:00Z" @default.
- Q99400507 P698 "32920421" @default.